Analyst Report from Bioshares
29 September 2017
David Blake and Mark Pachacz
LBT Innovations (LBT: $0.315) has installed its first APAS Independence instrument in Melbourne, at St Vincent’s Hospital. The site will be the first commercial hospital that will trial the product, which will be sold for around US$300,000.